v1
Corrigendum to "Review on 505(b)(2) Drug products approved by USFDA from 2010 to 2020 emphasizing intellectual property and regulatory considerations for reformulations and new combinations" [Journal of Pharmaceutical Sciences/ Volume 112, Issue 8, August 2023/ Pages 2146-2175].
NobleIDNI2P36W10R97S43
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260523/0FFFC9DA)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims